Laurel Wealth Advisors Inc. purchased a new position in shares of The Clorox Company (NYSE:CLX) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,115 shares of the company’s stock, valued at approximately $314,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. raised its stake in The Clorox by 63.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 417,347 shares of the company’s stock valued at $54,269,000 after purchasing an additional 161,555 shares during the last quarter. Vident Investment Advisory LLC purchased a new stake in The Clorox in the 3rd quarter valued at $1,477,000. Allianz Asset Management GmbH grew its holdings in The Clorox by 417.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 63,868 shares of the company’s stock valued at $8,425,000 after buying an additional 51,534 shares in the last quarter. Jensen Investment Management Inc. grew its holdings in The Clorox by 12.1% in the 4th quarter. Jensen Investment Management Inc. now owns 40,960 shares of the company’s stock valued at $6,092,000 after buying an additional 4,435 shares in the last quarter. Finally, Spearhead Capital Advisors LLC purchased a new stake in The Clorox in the 4th quarter valued at $2,846,000. Hedge funds and other institutional investors own 75.71% of the company’s stock.
A number of research firms have recently weighed in on CLX. Zacks Investment Research upgraded The Clorox from a “hold” rating to a “buy” rating and set a $163.00 price target for the company in a report on Monday, January 8th. BMO Capital Markets set a $147.00 target price on The Clorox and gave the stock a “buy” rating in a research note on Monday, February 5th. Morgan Stanley decreased their target price on The Clorox from $140.00 to $133.00 and set an “equal weight” rating on the stock in a research note on Monday, February 5th. Jefferies Group reaffirmed a “hold” rating and issued a $148.00 price target on shares of The Clorox in a research report on Thursday, January 4th. Finally, Wells Fargo reaffirmed a “hold” rating and issued a $130.00 price target on shares of The Clorox in a research report on Wednesday, December 13th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $136.19.
Shares of The Clorox stock traded down $1.74 during trading on Friday, reaching $128.51. The company’s stock had a trading volume of 950,370 shares, compared to its average volume of 1,007,540. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.22 and a quick ratio of 0.86. The Clorox Company has a 12-month low of $123.64 and a 12-month high of $150.40. The company has a market cap of $16,629.71, a PE ratio of 24.02, a price-to-earnings-growth ratio of 2.67 and a beta of 0.35.
The Clorox (NYSE:CLX) last posted its quarterly earnings results on Friday, February 2nd. The company reported $1.23 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.22 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.43 billion. The Clorox had a return on equity of 126.70% and a net margin of 13.21%. The company’s revenue for the quarter was up .7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.14 earnings per share. equities research analysts anticipate that The Clorox Company will post 5.66 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 11th. Investors of record on Wednesday, April 25th will be issued a dividend of $0.96 per share. The ex-dividend date is Tuesday, April 24th. This is a boost from The Clorox’s previous quarterly dividend of $0.84. This represents a $3.84 annualized dividend and a yield of 2.99%. The Clorox’s payout ratio is currently 62.80%.
TRADEMARK VIOLATION NOTICE: This piece was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/08/laurel-wealth-advisors-inc-invests-314000-in-clorox-co-clx-stock.html.
The Clorox Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.